Kiniksa Pharmaceuticals
KNSA
#4646
Rank
A$2.44 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
$33.68
Share price
-6.43%
Change (1 day)
22.84%
Change (1 year)

Revenue for Kiniksa Pharmaceuticals (KNSA)

Revenue in 2024 (TTM): A$0.64 Billion

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$0.70 Billion. an increase over the revenue in the year 2023 that were of A$0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kiniksa Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 A$0.68 B71.54%
2023 A$0.39 B22.6%
2022 A$0.32 B508.58%
2021 A$53.16 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA